Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: A meta-analysis

Anaesthesia and Intensive Care

Volumn 40, Issue 1, 2012, Pages 17-32

  Saw, M M ^a,b   Chandler, B ^a   Ho, K M ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Colloids; Outcomes; Resuscitation; Safety

Indexed keywords

ALBUMIN; GELATIN; INFUSION FLUID; PLASMA SUBSTITUTE; STARCH;

ACUTE KIDNEY FAILURE; BLEEDING; BLOOD TRANSFUSION; CRITICALLY ILL PATIENT; CRYSTALLOID; EMBASE; HUMAN; INTENSIVE CARE; MAJOR SURGERY; MEDLINE; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SURGICAL PATIENT; SYSTEMATIC REVIEW;

EID: 84856475720     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000104     Document Type: Review

References (42)

1. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256.
2. Hogan J. The intravenous use of colloidal (gelatine) solutions in shock. JAMA 1915; 64:721-726.
3. Jacobson S, Smyth C. Gelatin as a substitute for plasma, observations on its administration to human beings. Arch Intern Med 1944; 74:254-257.
4. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1:466-469. (Pubitemid 8045131)
5. Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L et al. Reduced quality of clot formation with gelatin- based plasma substitutes. Br J Anaesth 1998; 80:204-207. (Pubitemid 28069771)
6. Evans PA, Glenn JR, Heptinstall S, Madira W. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 1998; 81:198-202. (Pubitemid 28379363)
7. Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S et al. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth 1997; 78:44-50. (Pubitemid 27047411)
8. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006; 102:998-1006.
9. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 2010; 104:691-697.
10. Kuitunen A, Suojaranta-Ylinen R, Kukkonen S, Niemi T. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery. Scand J Surg 2007; 96:72-78. (Pubitemid 46493769)
11. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Raivio PM, Kukkonen SI, Niemi TT. Comparison of the effect of 6% hydroxyethyl starch and gelatine on cardiac and stroke volume index: a randomized, controlled trial after cardiac surgery. Perfusion 2010; 25:283-291.
12. Cochrane Information Management System Review Manager Software. From http://ims.cochrane.org/revman/download/revman-4 Accessed March 2011.
13. Asfar P, Kerkeni N, Labadie F, Gouello JP, Brenet O, Alquier P. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intensive Care Med 2000; 26:1282-1287.
14. Beards SC, Watt T, Edwards JD, Nightingale P, Farragher EB. Comparison of the hemodynamic and oxygen transport responses to modified fluid gelatin and hetastarch in critically ill patients: a prospective, randomized trial. Crit Care Med 1994; 22:600-605. (Pubitemid 24121560)
15. Boks RH, Wijers MJ, Hofland J, Takkenberg JJ, Bogers AJ. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference? Perfusion 2007; 22:333-337. (Pubitemid 351516045)
16. Gondos T, Marjanek Z, Ulakcsai Z, Szabo Z, Bogar L, Karolyi M et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol 2010; 27:794-800.
17. Inal MT, Memiş D, Karamanlioglu B, Sut N. Effects of polygeline and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients. J Crit Care 2010; 25:361.
18. Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002; 95:858-865.
19. Jin S-L, Yu B-W. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms. Clin Appl Thromb Hemost 2010; 16:91-98.
20. Karoutsos S, Nathan N, Lahrimi A, Grouille D, Feiss P, Cox DJ. Thrombelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 1999; 82:175-177. (Pubitemid 29057611)
21. Liang H, Yang C-X, Li H, Liu H-Z, Wang H-B. Effects of preoperative acute hypervolemic hemodilution on hypercoagulability of patients with colon cancer. Ai Zheng 2006; 25:1256-1260.
22. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007; 105:905-917. (Pubitemid 47479300)
23. Molnar Z, Mikor A, Leiner T, Szakmany T. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Med 2004; 30:1356-1360. (Pubitemid 38951718)
24. Mortelmans YJ, Vermaut G, Verbruggen AM, Arnout JM, Vermylen J, Van Aken H et al. Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Anesth Analg 1995; 81:1235-1242.
25. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann 2009; 17:368-372.
26. Parker MJ, Griffiths R, Boyle A. Preoperative saline versus gelatin for hip fracture patients; a randomized trial of 396 patients. Br J Anaesth 2004; 92:67-70. (Pubitemid 38054651)
27. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357:911-916. (Pubitemid 32247279)
28. Soares RR, Ferber L, Lorentz MN, Soldati MT. Intraoperative volume replacement: crystalloids versus colloids in surgical myocardial revascularization without cardiopulmonary bypass. Rev Bras Anestesiol 2009; 59:439-451.
29. Stockwell MA, Soni N, Riley B. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline. 1. Outcome and duration of stay in the intensive care unit. Anaesthesia 1992; 47:3-6.
30. Stockwell MA, Scott A, Day A, Riley B, Soni N. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia 1992; 47:7-9.
31. Tollofsrud S, Svennevig JL, Breivik H, Kongsgaard U, Ozer M, Hysing E et al. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand 1995; 39:671-677.
32. Trekova NA, Aksel'rod BA, Babalian GV, Zaitseva SV, Dement'eva II, Buniatian AA. Clinical and laboratory evaluation of 20% albumin (plasbumin) used in cardiosurgical patients. Anesteziol Reanimatol 2006; 2:18-21.
33. Upadhyay M, Singhi S, Murlidharan J, Kaur N, Majumdar S. Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr 2005; 42:223-231. (Pubitemid 40461538)
34. Van der Linden PJ, De Hert SG, Daper A, Trenchant A, Schmartz D, Defrance P et al. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anesth 2004; 51:236-241. (Pubitemid 39022427)
35. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005; 101:629-634. (Pubitemid 41208482)
36. Vanhoonacker J, Ongenae M, Vanoverschelde H, Donadoni R. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg 2009; 60:91-97.
37. Wahba A, Sendtner E, Strotzer M, Wild K, Birnbaum DE. Fluid therapy with Ringer's solution versus Haemaccel following coronary artery bypass surgery. Acta Anaesthesiol Scand 1996; 40:1227-1233. (Pubitemid 26411390)
38. Wahba A, Sendtner E, Birnbaum DE. Fluid resuscitation with Haemaccel vs. human albumin following coronary artery bypass grafting. Thorac Cardiovasc Surg 1996; 44:178-182. (Pubitemid 26317250)
39. Wu JJ, Huang MS, Tang GJ, Kao WF, Shih HC, Su CH et al. Hemodynamic response of modified fluid gelatin compared with lactated ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World J Surg 2001; 25:598-602. (Pubitemid 32441433)
40. Yap WW, Young D, Pathi V. Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass - a randomised controlled trial. Perfusion 2007; 22:57-61.
41. American Thoracic Society. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 2004; 170:1247-1259.
42. Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 1997; 78:684-689. (Pubitemid 27268079)